Ryan Flinn - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Ryan Flinn's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Ryan Flinn

Ryan Flinn

Verified

AI Correspondent/Contributor, BiotechTV

Oakl

Final Covers

biotech

Journalist Type

-

Seniority Positions

Industries

Medium Formats

Content

Total articles 148

  • Protein Responsible for Parkinson’s Disease Also Drives Melanoma Progression

    By Ryan Flinn| Managed Healthcare Executive Verified Researchers have uncovered a surprising mechanism linking Parkinson’s disease and melanoma, potentially explaining why people with one condition face higher risks of developing the other. The culprit: a protein called alpha-synuclein that plays dramatically different roles in neurons versus skin cancer cells.

    By Ryan Flinn · Managed Healthcare Executive

    Apr. 14, 2025

  • Gene Therapy Shows Promise for Fatal Heart Condition Tied to Friedreich Ataxia

    By Ryan Flinn| Managed Healthcare Executive Verified An experimental gene therapy from Lexeo Therapeutics may provide a new treatment option for Friedreich ataxia (FA) cardiomyopathy, a rare and often fatal heart complication tied to the neurodegenerative disorder. Interim results from two early-stage studies suggest the therapy not only boosts production of a crucial mitochondrial protein but also meaningfully improves heart function, the company said in a news release.

    By Ryan Flinn · Managed Healthcare Executive

    Apr. 10, 2025

  • Protein Responsible for Parkinson’s Disease Also Drives Melanoma Progression

    By Ryan Flinn| Managed Healthcare Executive Verified Researchers have uncovered a surprising mechanism linking Parkinson’s disease and melanoma, potentially explaining why people with one condition face higher risks of developing the other. The culprit: a protein called alpha-synuclein that plays dramatically different roles in neurons versus skin cancer cells.

    By Ryan Flinn · Managed Healthcare Executive

    Apr. 14, 2025

As seen in

Company Info

BiotechTV

BiotechTV is a global provider of drug development solutions, offering services such as consulting, clinical operations, biometrics, and clinical pharmacology. The company focuses on supporting biotech firms with strategic advice on drug development and market strategies, managing clinical trials, and providing statistical analysis for clinical research. In addition to its consulting and operational services, BiotechTV creates educational content to inform and engage audiences about the biotech sector. This includes video interviews and discussions with industry leaders, particularly through its "BioVenture Voices" series, which features insights from prominent figures in biotech venture capital. Founded by Brad Loncar, BiotechTV aims to enhance understanding of biotechnology and its advancements, serving as a valuable resource for professionals in the industry.

Oakland, United States

Founded: 2023